Investments abroad · VC firm · Switzerland

Novartis' investments in the United States

Novartis, based in Switzerland, has backed 44 startups in the United States in rounds we track, $5.8B between them, grouped by their main sector.

44startups backed
4sectors
$5.8Braised between them
Biotechbiggest sector

Novartis's whole portfolioNovartis's profile

Segment by segment

Biotech

34 startups · $4.6B raised

  1. FreenomeFreenome is a biotechnology company with a comprehensive multiomics platform for cancer detection using a routine blood draw.United States$553M
  2. Intellia TherapeuticsIntellia Therapeutics is a genome editing company that develops curative gene-editing treatments.United States$485M
  3. Arcus BiosciencesArcus Biosciences is a biopharmaceutical company that discovers, develops, and commercializes novel therapies for the treatment of cancer.United States$427M
  4. Dren BioDren Bio focuses on protein engineering technologies for depletion of cells, protein aggregates, and other disease-causing agents.United States$375M
  5. Pear TherapeuticsPear Therapeutics is a Massachusetts-based prescription digital therapeutic platform that offers solutions such as clinical engageUnited States$239M
  6. Science 37Science 37 is a clinical research company that facilitates universal participation in clinical trials for patients and providers.United States$236M
  7. Aktis OncologyAktis Oncology is a biotechnology company discovering and developing a novel class of targeted radiopharmaceuticals.United States$175M
  8. Rani TherapeuticsRani is a clinical-stage biotherapeutics company that enables the development of orally administered biologics to improve patient outcomes.United States$168M

Pharma

5 startups · $622M raised

  1. Poseida TherapeuticsPoseida Therapeutics is a biopharmaceutical company utilizing gene engineering capabilities to develop targeted therapeutics.United States$217M
  2. Adicet BioAdicet Bio is a biotechnology company discovering and developing first-in-class allogeneic gamma delta CAR t cell therapies for caUnited States$175M
  3. Flare TherapeuticsFlare Therapeutics is a clinical-stage biotechnology company based in Cambridge, MA, founded in 2021.United States$123M
  4. Thesan PharmaceuticalsThesan Pharmaceuticals is a preclinical biopharmaceutical company developing novel therapeutics for skin disorders.United States$65M
  5. Soteria BiotherapeuticsSoteria Biotherapeutics is an immuno-oncology biotechnology company founded in 2018, focused on developing innovative therapies foUnited States$42M

Healthtech

3 startups · $540M raised

  1. CleerlyCleerly is a digital healthcare technology company based in Denver, founded in 2017.United States$372M
  2. Cala HealthCala Health is a bioelectronic medicine company based in San Mateo, California, founded in 2013.United States$150M
  3. RxLightningRxLightning automates the manual enrollment process of starting a patient on specialty medications.United States$18M

AI

2 startups · $65M raised

  1. OctaveOctave Capital partners with venture-backed and founder run technology companies to provide flexible growth capital and liquidity.United States$65M
  2. ParrotsSaaS AI/ML platform providing real-time voice and telecare to people with neurological disordersUnited States$20K

How this map is made. Every startup here has raised money in a round we track that names Novartis as an investor and is based in United States. Each sits under its main sector, read from its rounds, and each shows its best-funded first. Rebuilt nightly; updated 15 November 2026.

More portfolio maps

All portfolios

Raising from investors like Novartis?

Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.